drugset / Trial / NCT00711165
Mometasone and Markers of Airway Inflammation
RandomizedParallel-groupTriple-blindTreatment
Summary
A post-marketing study to look at the effects of Asmanex on markers of airway inflammation.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-04
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 400 ug | Inhaled |